NDC 82249-611 – Yulithira
Everolimus 5 mg/1 · Tablet · Oral
Product NDC82249-611
Product details
- Brand name
- Yulithira
- Generic name
- Everolimus
- Labeler
- CivicaScript, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA205426
- Marketed since
- March 5, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor; mTOR Inhibitor Immunosuppressant
Active ingredients
- Everolimus 5 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82249-611-30 | 30 TABLET in 1 BOTTLE (82249-611-30) | Jun 11, 2026 |